• Home
  • Newsroom

Humana Extends Medicare Prescription Drug Transition Policy for New Enrollees

Category:

Thursday, January 26, 2006 2:58 pm EST

Dateline:

LOUISVILLE, Ky.

Public Company Information:

NYSE:
HUM
US4448591028
"Allowing them more time to transition into the Medicare prescription drug plans also means they will have better information available as they discuss possible alternatives with their physicians."
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 26, 2006--When the Medicare Part D plans took effect Jan. 1, 2006, Humana implemented a transition plan for new prescription drug plan enrollees as they began using their Humana Medicare prescription drug benefit for the first time. Those impacted were enrollees with prescriptions for certain classes of drugs which would normally have required prior authorization or so-called "step therapy" before being approved. The transition policy allowed a 30-day grace period during which the plan member was not subject to those requirements.

Today, Humana Inc. (NYSE: HUM) has announced that it has taken the initiative to expand its transition policy from 30 days to 60 days for all new enrollees in the Medicare Part D prescription drug plan. In order to make the transition into the new plans as smooth as possible, Humana has extended its transition policy to ensure that its new enrollees understand their new prescription drug benefits and have time to talk with their doctors.

Within its transition policy, Humana has launched a communication campaign to educate the new member about their medications that may have required prior authorization or step therapy per the formulary requirements. This outreach campaign will send members letters that will outline choices and options the member should discuss with their physician concerning their pharmaceutical care needs.

"We believe the extension of this transition policy will help our members get access to their medications as they become more familiar with these new benefit plans," said William Fleming, PharmD, vice president of Pharmacy and Clinical Integration for Humana. "Allowing them more time to transition into the Medicare prescription drug plans also means they will have better information available as they discuss possible alternatives with their physicians."

This transition policy goes into effect immediately for all of Humana's Part D members.

As part of the outreach program, Humana will revise the transition process notice currently included on the company's website, www.humana-medicare.com.

About Humana

Humana Inc., headquartered in Louisville, Kentucky, is one of the nation's largest publicly traded health benefits companies, with approximately 7 million medical members. Humana offers a diversified portfolio of health insurance products and related services - through traditional and consumer-choice plans - to employer groups, government-sponsored plans, and individuals.

Over its 45-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.

More information regarding Humana is available to investors via the Investor Relations page of the company's web site at http://www.humana.com, including copies of:

-- Annual report to stockholders;

-- Securities and Exchange Commission filings;

-- Most recent investor conference presentation;

-- Quarterly earnings news releases;

-- Replays of most recent earnings release conference call;

-- Calendar of events (includes upcoming earnings conference call dates, times, and access number, as well as planned interaction with institutional investors);

-- Corporate Governance Information.

Contact:

Humana Corporate Communications
Dick Brown, 502-580-3683
dbrown4@humana.com